Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00871312 · ClinicalTrials.gov registry record · NA
Evaluation of Topical Wound Oxygen (two2) Therapy
A NA study, sponsored by AOTI.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT00871312 is a NA study that was terminated before completion, run by AOTI. The registered enrollment target is 21 participants.
The verdict
NCT00871312, a NA study, was terminated before completion, sponsored by AOTI.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of the Topical Wound Oxygen (two2) therapy system on the healing of diabetic lower extremity ulcers.
Interventions
- DEVICE Topical wound oxygen therapy
- DEVICE Topical wound oxygen Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00871312
The ClinicalTrials.gov registry entry for NCT00871312 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AOTI, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topical wound oxygen therapy is the first listed.
NCT00871312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00871312 about?
NCT00871312 is a clinical study titled "Evaluation of Topical Wound Oxygen (two2) Therapy". The purpose of this study is to evaluate the efficacy of the Topical Wound Oxygen (two2) therapy system on the healing of diabetic lower extremity ulcers.
What is the current status of trial NCT00871312?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2007-05. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00871312?
The interventions under investigation include: Topical wound oxygen therapy (DEVICE), Topical wound oxygen Placebo (DEVICE).
Who is sponsoring clinical trial NCT00871312?
This trial is sponsored by AOTI, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.